Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Colwell

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
The Journal of Bone and Joint Surgery. American Volume|July 31, 1999
Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after dischargeC W Colwell, D K Collis, R Paulson, et al.
The Journal of Bone and Joint Surgery. American Volume|November 1, 1994
Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplastyJ C Grady-Benson, C S Oishi, P B Hanson, et al.
Clinical Orthopaedics and Related Research|February 29, 2000
Bilobed oblong porous coated acetabular components in revision total hip arthroplastyD J Berry, C J Sutherland, R T Trousdale, et al.
Chest|February 7, 2001
Prevention of venous thromboembolismW H Geerts, J A Heit, G P Clagett, et al.
Clinical Orthopaedics and Related Research|October 18, 2001
In vivo changes after mechanical injuryC W Colwell, D D D'Lima, H R Hoenecke, et al.
The Journal of Bone and Joint Surgery. American Volume|January 1, 1994
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial GroupC W Colwell, T E Spiro, A A Trowbridge, et al.
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind studyC W Colwell, S D Berkowitz, B L Davidson, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Journal of Bone and Joint Surgery. American Volume|July 31, 1999
Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after dischargeC W Colwell, D K Collis, R Paulson, et al.
The Journal of Bone and Joint Surgery. American Volume|November 1, 1994
Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplastyJ C Grady-Benson, C S Oishi, P B Hanson, et al.
Clinical Orthopaedics and Related Research|February 29, 2000
Bilobed oblong porous coated acetabular components in revision total hip arthroplastyD J Berry, C J Sutherland, R T Trousdale, et al.
Chest|February 7, 2001
Prevention of venous thromboembolismW H Geerts, J A Heit, G P Clagett, et al.
Clinical Orthopaedics and Related Research|October 18, 2001
In vivo changes after mechanical injuryC W Colwell, D D D'Lima, H R Hoenecke, et al.
The Journal of Bone and Joint Surgery. American Volume|January 1, 1994
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial GroupC W Colwell, T E Spiro, A A Trowbridge, et al.
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind studyC W Colwell, S D Berkowitz, B L Davidson, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Pageof 9